Insider Trades of ORBIMED ADVISORS LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▼ Type Tran OwnerType Shares Traded Last Price Shares Held
SIENTRA, INC. Beneficial Owner (10%) 09/29/2015 Form 4 Sell indirect 10,558 10.08 28,611
SIENTRA, INC. Beneficial Owner (10%) 09/28/2015 Form 4 Sell indirect 10,602 10.3 3,034,400
SIENTRA, INC. Beneficial Owner (10%) 09/25/2015 Form 4 Sell indirect 132,000 10.07 28,789
SIENTRA, INC. Beneficial Owner (10%) 09/24/2015 Form 4 Sell indirect 8,306 9.78 29,900
INTERCEPT PHARMACEUTICALS INC Director 07/17/2015 Form 4 Acquisition (Non Open Market) indirect 285 0 1,120,609
PIERIS PHARMACEUTICALS, INC. Director 07/06/2015 Form 4 Buy indirect 500,000 2.75 7,259,620
GLAUKOS CORP Director 06/30/2015 Form 4 Acquisition (Non Open Market) indirect 2,882,064 0 2,854,870
GLAUKOS CORP Director 06/30/2015 Form 4 Disposition (Non Open Market) indirect 11,734 18 2,897,937







Create your free portfolio




Most Rated Stocks of Last Week

Rated stocks for NASDAQ, NYSE and AMEX

Symbol / Ratings Consensus

AAPL 86% bullish of 2876 ratings Rate It

DRYS 73% bullish of 45 ratings Rate It

MSFT 84% bullish of 644 ratings Rate It

BAC 75% bullish of 469 ratings Rate It

F 83% bullish of 322 ratings Rate It

INTC 83% bullish of 266 ratings Rate It

NOK 74% bullish of 211 ratings Rate It

BABA 77% bullish of 163 ratings Rate It

GILD 91% bullish of 122 ratings Rate It

PFE 92% bullish of 50 ratings Rate It